Abstract
Background
Sleep-disordered breathing (SDB) may contribute to development of stroke. However, findings are inconclusive. We investigated whether SDB-related symptoms are associated with incidence of stroke and its types in a general community sample of adult men and women as well as to perform Mendelian randomization (MR) analysis.
Methods
We used data from a cohort of 41,742 Swedish adults (56–94 years of age) who completed questionnaires regarding snoring, cessation of breathing, lifestyle and health characteristics. Participants were followed up for incident stroke and death over 8 years through linkage to the Swedish Registers. Hazard ratios, adjusted for potential confounders, were estimated by Cox proportional hazards regression. MR analyses were performed using single-nucleotide polymorphisms associated with sleep apnea at the genome-wide significance level and summary-level data for stroke and its subtypes from consortia and a meta-analysis of Genome-Wide Association Studies.
Results
In the cohort study, symptoms of disturbing snoring and/or cessation of breathing were associated with increased risk of total stroke (hazard ratio 1.12, 95% confidence interval 1.02–1.24) and intracerebral hemorrhage (hazard ratio 1.59, 95% confidence interval 1.23–2.05) but not with ischemic stroke or subarachnoid hemorrhage. MR analyses showed no association of genetic liability to sleep apnea with the risk of overall stroke or any specific types of stroke or ischemic stroke subtypes.
Conclusions
SDB-related symptoms were associated with increased risk of total stroke, specifically intracerebral hemorrhage, in the observational analyses but not in the MR analyses. There was limited evidence of an association of SDB with ischemic stroke and subarachnoid hemorrhage.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Stroke is one the leading causes of long-term disability and mortality worldwide. Hypertension, diabetes, and smoking are among the most commonly described modifiable risk factor for stroke [6]. In addition, evidence suggests that sleep-disordered breathing (SDB) may also contribute to the development of stroke [16,17,18].
Obstructive sleep apnea (OSA), the most prevalent type of SDB, is characterized by repeated episodes of either partial or full cessation of breathing during sleep. The prevalence of OSA increases with age, and men and obese individuals are more likely to suffer from this condition. Loud snoring, sleep-related breathing problems, and daytime sleepiness are frequent symptoms of OSA [22]. Although SDB is frequently emphasized to be associated with long-term health consequences, this disorder both remains often undiagnosed [19] and admittedly, without often firm causal evidence of disease association. Sleep laboratory studies have demonstrated high prevalence of OSA in stroke patients [12]. However, large prospective cohort studies are needed to investigate whether SDB may increase risk of specific stroke independently of obesity in participants with no history of stroke at baseline.
Previous cohort studies of the association between SDB and subsequent stroke has focused on overall or ischemic stroke and results are inconsistent. Some cohort studies have demonstrated an approximately 2- to fourfold increased risk of incident stroke among participants with OSA [16,17,18], whereas other studies found no association [3, 32]. No prospective study today has investigated the association between SDB-related symptoms and incidence of hemorrhagic stroke and subarachnoid hemorrhage (SAH). Conventional observational studies are prone to confounding and reverse causality biases that can be reduced by the Mendelian randomization (MR) design [10]. MR is an epidemiologic technique that utilizes genetic variants that strongly associate with the modifiable risk factors to estimate their causal role for the risk of disease [23].
The aim of this study was to investigate the association of self-reported SDB-related symptoms with overall stroke and specific stroke types in a cohort of 41,742 middle-aged and elderly men and women. In addition, we performed a 2-sample MR study to explore whether sleep apnea is associated with overall stroke or any stroke subtype.
Methods
Study population
In the primary analysis, we used data from the National Research Infrastructure SIMPLER (Swedish Infrastructure for Medical Population-based Life-course Environmental Research). A detailed description of the cohort infrastructure can be found elsewhere (https://www.simpler4health.se). Information on lifestyle and other risk factors for chronic diseases was obtained via structured questionnaires in 2008–2009 and used as baseline in the present study. From 47,812 participants who completed the questionnaires in 2008–2009, we excluded individuals who died prior to July 1, 2009 (n = 44); and those who had missing information on SDB (n = 4144). We further excluded 1882 participants with a diagnosis of any stroke before start of a follow-up, as ascertained through linkage to the Swedish National Patient Register. After exclusions, 41,742 participants (18,692 women and 23,050 men) with a mean baseline age of 69 (56–94) remained for analysis. The cohort study was approved by the Swedish Ethical Review Authority and written informed consent has been obtained from the participants.
Exposure assessment
In 2008/2009, participants completed questionnaires which included information about snoring, cessation of breathing, educational attainment, smoking status, alcohol consumption, weight, height, physical activity, and history of diabetes, hypertension and hypercholesterolemia. Participants reported how often they experienced sleep apnea or cessation of breathing as well as disturbing snoring during the past 3 months with the following options: never; seldom; often; mostly and always. Participants who indicated that they experienced sleep apnea/cessation of breathing or snoring often, mostly or always were defined as having SDB symptoms.
Case ascertainment and follow-up
Cases of stroke and death were determined through linkage with the Swedish National Patient Register (covering both in- and out-patients) and the Cause of Death Register using the unique personal identity number assigned to each Swedish resident and classified according to the International Classification of Diseases, ICD, 10th Revision codes. The endpoints in the present study were acute ischemic stroke (I63), intracerebral hemorrhage, ICH (I61), subarachnoid hemorrhage (I60), and unspecified stroke (I62). Participants were followed up from July 1, 2009 to the date of diagnosis of CVD, death from any cause, or December 31, 2017, whichever occurred first.
Two-sample MR analysis
We used publicly available summarized data for genetic associations with overall and ischemic stroke from the MEGASTROKE consortium [15], ICH from the International Stroke Genetics consortium [29] and subarachnoid hemorrhage from a meta-analysis of Genome-Wide Association Studies (GWASs) on intracranial aneurysms [4]. Studies included in the consortia were approved by local research ethics committees and institutional review boards and all participants provided written informed consent. The MEGASTROKE consortium included 446,696 individuals of European ancestry (406,111 non-cases and 40,585 cases of any stroke); the number of cases of ischemic stroke was 34,217 overall, 3373 for large-artery atherosclerotic stroke (LAS), 5386 for small vessel stroke, and 7193 for cardioembolic stroke. The Trial of ORG 10172 in Acute Stroke Treatment criteria was used to subtype ischemic stroke. Summary statistics data for hemorrhagic stroke were available from two meta-analyses of GWASs (ICH: 3223 cases and 3725 non-cases and subarachnoid hemorrhage: 7495 cases and 71,934 non-cases). The MR analysis was approved by the Swedish Ethical Review Authority.
Instrumental variable selection
Thirty-nine single-nucleotide polymorphisms (SNPs) associated with sleep apnea at the level of genome-wide significance (p < 5 × 10−8) were identified from a meta-analysis of five cohorts and a previous GWAS including a total of 510,484 participants of European ancestry [8]. These SNPs were replicated in 23andMe and this GWAS analysis was adjusted for sex, age, BMI, genetic principal components and genotype platform [8]. Linkage disequilibrium across 39 SNPs were assessed using the TwoSampleMR package. We used 35 independent SNPs (r2 < 0.01 and clump distance > 10 kb in European populations) as instrument variables for sleep apnea. The used SNPs for sleep apnea explained around 0.98% of phenotypic variance. The summary-level effect size (beta and standard error) of sleep apnea-associated SNPs were estimated based on the population from 23andMe. Details of the SNPs used as instrumental variables are available in Supplementary Table I.
Statistical analysis
In our analysis based on the SIMPLER’s cohort data, Cox proportional hazards regression models were used to estimate hazard ratios (HR) with corresponding 95% confidence intervals (CI) with age as the time scale and adjusted for sex (as a stratification variable) in the basic model. In a first multivariable model, we additionally adjusted for body mass index (weight divided by the square of height; < 22.5; 22.5–24.9; 25.0–29.9; or ≥ 30 kg/m2). In a second multivariable model, we further adjusted for education (less than high school, high school, or university), smoking status (never, former, current smokers), alcohol intake (never drinkers; past or current drinkers of < 1 drink/week; 1– < 7 drinks/week; 7– < 15 drinks/week; 15–21 drinks/week; > 21 drinks/week), walking/bicycling (never/seldom; < 20 min/day; 20–40 min/day; > 40 min/day), exercise (almost never; < 1 h/week; 1 h/week; 2–3 h/week; 4–5 h/week; ≥ 5 h/week), and history of diabetes (yes/no), hypertension (yes/no), and hypercholesterolemia (yes/no). In a sensitivity analyses, we additionally adjusted for cohabitation status (cohabiting vs not cohabiting). In the primary analysis, SDB was treated as a dichotomous variable (no SDB symptoms vs at least one SDB symptom which occurred often, mostly or always). In secondary analyses, we considered the number of SDB symptoms as an exposure variable: no SDB symptoms, snoring or sleep apnea/cessation of breathing or both snoring and sleep apnea/cessation of breathing.
Schoenfeld residuals were used to test the proportional hazards assumption. No interaction between SDB and age was observed in a basic model with regards to stroke outcomes (P for interaction > 0.2). The association between SDB and stroke outcomes did not differ by sex (all P for interaction > 0.2), and all analyses were conducted for men and women combined. The proportion of missing data on the potential confounders used in the main analysis was less than 3% except for smoking status which had less than 7% of missing values. A separate category was created for each variable containing missing values. Potential confounders were selected using directed acyclic graphs [26] based on our a priori knowledge of the relationships among potential confounders, intermediate variables, exposure, and outcome variables, and on existing information regarding factors associated with stroke and SDB [1, 25]. All statistical tests were two sided and p values below 0.05 were considered statistically significant. All statistical analyses were performed using Stata version 15.1 (StataCorp, College Station, TX, USA).
The MR analysis was conducted using the random-effects inverse-variance weighted (IVW) method and supplemented with the weighted median, MR-Egger and MR Pleiotropy Residual Sum and Outlier (PRESSO) methods. The MR-Egger method was used to assess directional pleiotropy [7], whereas the MR-PRESSO method was used to detect potential outlier SNPs [27]. Reported odds ratios (OR) with corresponding 95% confidence intervals (CI) were scaled to one unit increase in log odds of genetic predisposition to sleep apnea. The MR analysis was performed using the mrrobust package in Stata (StataCorp LP, College Station, TX) [24] and the TwoSampleMR and MR-PRESSO packages in R (R Foundation for Statistical Computing, Vienna, Austria) [31].
Results
Cohort study
The cohort consisted of 23,050 men and 18,692 women. Among them, 3259 participants (7.8%) reported cessation of breathing and 9569 (22.9%) indicated disturbing snoring. 30.7% of men and 16% of women reported having at least one SDB characteristic (snoring or cessation of breathing); 9.2% of men and 3.6% of women indicated that they experienced both snoring and cessation of breathing. Baseline characteristics of study participants according to SDB are shown in Table 1. Compared with those without snoring or cessation of breathing, individuals who reported these SDB symptoms were somewhat younger, were more likely to be men, had higher alcohol intake, were more likely to be former or current cigarette smokers, were less physically active, had higher BMI, and were more likely to have history of hypertension, hypercholesterolemia, and diabetes.
The number of incident stroke events during up to 8 years of follow-up is shown in Tables 2 and 3. In the multivariable model, having at least one SDB symptom was associated with increased risks of total stroke and of ICH, but not with ischemic stroke or SAH (Table 2). The presence of both SDB symptoms was associated with increased risk of total stroke in the model adjusted for age, sex and BMI (Table 3). However, this association was only marginally statistically significant after adjustment for all potential confounders (Table 3). The analysis of the relationship of number of SDB-related symptoms and risk of stroke, confirmed that having either snoring or cessation of breathing, was linked to higher risk of ICH. However, having both SDB-related symptoms was not associated with risk of ICH (p > 0.05), although the direction of the association was the same (Table 3). The association between number of SDB symptoms and SAH is not presented in Table 3 due to small number of cases in exposure groups. Sensitivity analysis, with additional adjustment for cohabitation status (no/yes), revealed similar results with no change in the HR or a slight change in the second decimal point (data not shown).
Two-sample MR analysis
There was no association of genetic liability to sleep apnea with overall risk of stroke or any ischemic or hemorrhagic stroke subtypes (Fig. 1). The lack of association remained in sensitivity analyses. There was no evidence of directional pleiotropy, and no outliers were identified (Supplementary Table II).
Discussion
The present study used a cohort study design and MR approach to evaluate the association between symptoms of SDB and stroke types and subtypes. In the cohort study, an increased risk of total stroke and ICH in particular was observed among individuals with at least one SDB-related symptom (disturbing snoring or cessation of breathing). However, genetic liability to sleep apnea was not associated with overall stroke or ICH in the MR-analyses. There was little evidence of associations of SDB-related traits with risk of ischemic stroke and subarachnoid hemorrhage.
Comparisons with other studies
Our findings of a positive association between self-reported symptoms of SDB and risk of total stroke are consistent with previous research based on objectively measured OSA [16]. Results of a recent meta-analysis of cohort studies demonstrated that severe OSA was linked to a 2.2-fold higher risk of stroke [30]. However, no association of mild or moderate OSA and risk of stroke was found [30]. Little is known about the link between SDB and risk of specific stroke types. In our study, we did not observe a significant association between symptoms of SDB and risk of ischemic stroke. In contrast, a 6-year longitudinal study of 394 elderly participants did find an association with severe OSA (defined as apnea–hypopnea index, AHI ≥ 30) [18]. The discrepancy in results might be related to differences in the definition of SDB, since we could not properly account for the severity of the SDB. In contrast to our study, a recent retrospective analysis based on clinical data of 10,621 patients with different sleep disorders found that a diagnosis of OSA was associated with a 6.8-fold higher risk of SAH compared to patients with other sleep disorders [33]. Of note, no adjustment for any confounding factor (e.g., sex, age, smoking, BMI) or comparison with a healthy control group was possible in that study [33]. Furthermore, the incidence of SAH in our study was low and we cannot exclude that weak associations might be overlooked. We are not aware of any previous cohort study on SDB in relation to risk of hemorrhagic stroke (ICH or SAH). In the present cohort, those who suffered either from disturbing snoring or cessation of breathing had a 59% higher risk of ICH compared to individuals without SDB-related symptoms. The lack of association between having both disturbing snoring and cessation of breathing and the risk of ICH, may be due to small number of cases in this subgroup (n = 25).
Our secondary MR analyses showed no significant association between genetic liability to sleep apnea and stroke. However, these findings in relation to ICH should be interpreted with caution due to the small sample size and low precision. Further cohort and MR studies based on larger GWAS are needed to investigate the relationship between SDB and the risk of hemorrhagic stroke.
Potential mechanisms
The mechanisms underlying the link between SDB and stroke may involve several pathways. SDB is associated with sleep fragmentation, intermittent hypoxia, inflammation, oxidative stress, endothelial dysfunction [21, 28] and decrease in the nocturnal dipping of blood pressure, [9] all of which may contribute to increased risk of stroke. ICH is usually caused by rupture of blood vessels that have degenerated, possibly due to long-term hypertension [2]. In addition, a recent meta-analysis of 28 case–control studies, indicated that OSA was associated with a decreased flow-mediated dilatation, a measure of endothelial dysfunction [28], which may play a role in brain changes related to cerebral small vessel disease [20]. Such changes may predispose to the poorer functional outcomes following ICH [13].
Strength and limitations
Important strengths of our cohort study are the large sample size and large number of incident stroke cases objectively assessed through linkage to nationwide population-based registers; complete case identification and no loss to follow-up; and the ability to adjust for important confounders. In addition, the association of symptoms of SDB with several stroke subtypes was investigated, and both men and women were included in this study. Several limitations, however, apply to the present observational study. The information on subtypes of ischemic stroke was not available and the incidence of SAH and ICH among individuals with symptoms of SDB was low, which could increase the risk of type 2 error. SDB-related symptoms were determined based on self-reports and we were unable to determine the severity of the SDB. This could explain the smaller magnitude of associations between SDB symptoms and, for example, total stroke compared to other studies utilizing objective measures (e.g., polysomnography).
Self-reported snoring and cessation of breathing were used here as a proxy for SDB. Already in 1991 it was shown that, independent of age and sex, self-reported snoring frequency is associated with a higher likelihood of sleep apnea as assessed by polysomnography [5]. Hence, snoring is included in all screening instruments for OSA and widely used in epidemiological studies when the objective evaluation with polysomnography is not possible, e.g., due to large sample size. When creating a scoring scale for SDB, the questions on snoring and breathing cessation turned out to have the highest correlation with a scoring scale with adequate reliability for sleep-disordered breathing as identified with polysomnography [11]. In a recent study, the predictive value of several OSA screening instruments was explored, and the authors concluded that self-reported observed apnea had the strongest association with moderate sleep apnea (apnea–hypopnea index ≥ 15) [14]. However, although both snoring and cessation of breathing have high predictive value for OSA, the exact validity remains unknown; and as no polysomnography was performed in this cohort we have no information on severity of SDB.
Another limitation is that we have no information on treatment for SDB during the follow-up period, and the association between SDB symptoms and stroke could thereby be underestimated in our study. Finally, in view of the observational nature of this study, we cannot rule out residual and unmeasured confounding (e.g., additional potential confounders, such as medication, were not included in the analyses).
The major strength of our MR study includes the large number of overall stroke and total ischemic stroke cases and data on etiologic subtypes of ischemic stroke; and that potential confounding and reverse causality, which can bias the findings from conventional observational studies, were reduced by the use of genetic variants as proxy measures for sleep apnea. In addition, our MR analysis was restricted to European descent individuals which reduced potential bias due to population stratification. Finally, methods to correct for possible pleiotropy and identify potential outliers SNPs were used. An important limitation is that the analysis of the association between genetically predicted sleep apnea and ICH was based on a small sample, and we cannot exclude that a weak association was overlooked. Thus, further large studies in other populations are needed.
Conclusions
Results from this large-scale cohort study of middle-aged and older individuals showed that self-reported markers of SDB such as snoring and breathing cessations were associated with an increased risk of total stroke and ICH, but not with ischemic stroke or subarachnoid hemorrhage. Two-sample MR analysis showed no evidence of an association of sleep apnea and any stroke outcome but had limited power in the analysis of ICH. Thus, the association between SDB and ICH needs further study.
Data availability
The data that support findings of the prospective cohort study are available upon application to the Swedish Infrastructure for Medical Population-Based Life-Course Environmental Research (https://www.simpler4health.se). Data used for the MR analyses are publicly available from the MEGASTROKE consortium (https://www.megastroke.org/) [15], the International Stroke Genetics Consortium (https://strokegenetics.org/) [29] and a meta-analysis of Genome-Wide Association Studies [4].
References
Al Lawati NM, Patel SR, Ayas NT (2009) Epidemiology, risk factors, and consequences of obstructive sleep apnea and short sleep duration. Prog Cardiovasc Dis 51:285–293
An SJ, Kim TJ, Yoon BW (2017) Epidemiology, risk factors, and clinical features of intracerebral hemorrhage: an update. J Stroke 19:3–10
Arzt M, Young T, Finn L, Skatrud JB, Bradley TD (2005) Association of sleep-disordered breathing and the occurrence of stroke. Am J Respir Crit Care Med 172:1447–1451
Bakker MK, van der Spek RAA, van Rheenen W, Morel S, Bourcier R, Hostettler IC, Alg VS, van Eijk KR, Koido M, Akiyama M, Terao C, Matsuda K, Walters RG, Lin K, Li L, Millwood IY, Chen Z, Rouleau GA, Zhou S, Rannikmae K, Sudlow CLM, Houlden H, van den Berg LH, Dina C, Naggara O, Gentric JC, Shotar E, Eugene F, Desal H, Winsvold BS, Borte S, Johnsen MB, Brumpton BM, Sandvei MS, Willer CJ, Hveem K, Zwart JA, Verschuren WMM, Friedrich CM, Hirsch S, Schilling S, Dauvillier J, Martin O, Stroke HA-I, China Kadoorie Biobank Collaborative G, BioBank Japan Project C, Group IS, Group C, Genetics, Observational Subarachnoid Haemorrhage Study i, International Stroke Genetics C, Jones GT, Bown MJ, Ko NU, Kim H, Coleman JRI, Breen G, Zaroff JG, Klijn CJM, Malik R, Dichgans M, Sargurupremraj M, Tatlisumak T, Amouyel P, Debette S, Rinkel GJE, Worrall BB, Pera J, Slowik A, Gaal-Paavola EI, Niemela M, Jaaskelainen JE, von Und Zu, Fraunberg M, Lindgren A, Broderick JP, Werring DJ, Woo D, Redon R, Bijlenga P, Kamatani Y, Veldink JH, Ruigrok YM (2020) Genome-wide association study of intracranial aneurysms identifies 17 risk loci and genetic overlap with clinical risk factors. Nat Genet 52:1303–1313
Bliwise DL, Nekich JC, Dement WC (1991) Relative validity of self-reported snoring as a symptom of sleep apnea in a sleep clinic population. Chest 99:600–608
Boehme AK, Esenwa C, Elkind MS (2017) Stroke risk factors, genetics, and prevention. Circ Res 120:472–495
Bowden J, Davey Smith G, Burgess S (2015) Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol 44:512–525
Campos AI, Ingold N, Huang Y, Kho PF, Han X, Ong J-S, Garcia-Marin LM, Law MH, Martin NG, Dong X, Cuellar-Partida G, MacGregor S, Aslibekyan S, Renteria ME (2020) Genome-wide analyses in 1,987,836 participants identify 39 genetic loci associated with sleep apnoea. medRxiv:2020. https://doi.org/10.1101/2020.09.29.20199893
Cuspidi C, Tadic M, Sala C, Gherbesi E, Grassi G, Mancia G (2019) Blood pressure non-dipping and obstructive sleep apnea syndrome: a meta-analysis. J Clin Med 8:1367
Davies NM, Holmes MV, Davey Smith G (2018) Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians. BMJ 362:k601
Douglass AB, Bornstein R, Nino-Murcia G, Keenan S, Miles L, Zarcone VP Jr, Guilleminault C, Dement WC (1994) The sleep disorders questionnaire. I: Creation and multivariate structure of SDQ. Sleep 17:160–167
Johnson KG, Johnson DC (2010) Frequency of sleep apnea in stroke and TIA patients: a meta-analysis. J Clin Sleep Med 6:131–137
Kimura Y, Miwa K, Takasugi J, Oyama N, Todo K, Sakaguchi M, Mochizuki H, Sasaki T (2020) Total small vessel disease score and functional outcomes following acute intracerebral hemorrhage. J Stroke Cerebrovasc Dis 29:105001
Liamsombut S, Kaw R, Wang L, Bena J, Andrews N, Collop N, Stierer T, Gillinov M, Tarler M, Kayyali H, Katzan I, Foldvary-Schaefer N (2021) Predictive value of sleep apnea screenings in cardiac surgery patients. Sleep Med 84:20–25
Malik R, Chauhan G, Traylor M, Sargurupremraj M, Okada Y, Mishra A, Rutten-Jacobs L, Giese AK, van der Laan SW, Gretarsdottir S, Anderson CD, Chong M, Adams HHH, Ago T, Almgren P, Amouyel P, Ay H, Bartz TM, Benavente OR, Bevan S, Boncoraglio GB, Brown RD Jr, Butterworth AS, Carrera C, Carty CL, Chasman DI, Chen WM, Cole JW, Correa A, Cotlarciuc I, Cruchaga C, Danesh J, de Bakker PIW, DeStefano AL, den Hoed M, Duan Q, Engelter ST, Falcone GJ, Gottesman RF, Grewal RP, Gudnason V, Gustafsson S, Haessler J, Harris TB, Hassan A, Havulinna AS, Heckbert SR, Holliday EG, Howard G, Hsu FC, Hyacinth HI, Ikram MA, Ingelsson E, Irvin MR, Jian X, Jimenez-Conde J, Johnson JA, Jukema JW, Kanai M, Keene KL, Kissela BM, Kleindorfer DO, Kooperberg C, Kubo M, Lange LA, Langefeld CD, Langenberg C, Launer LJ, Lee JM, Lemmens R, Leys D, Lewis CM, Lin WY, Lindgren AG, Lorentzen E, Magnusson PK, Maguire J, Manichaikul A, McArdle PF, Meschia JF, Mitchell BD, Mosley TH, Nalls MA, Ninomiya T, O’Donnell MJ, Psaty BM, Pulit SL, Rannikmae K, Reiner AP, Rexrode KM, Rice K, Rich SS, Ridker PM, Rost NS, Rothwell PM, Rotter JI, Rundek T, Sacco RL, Sakaue S, Sale MM, Salomaa V, Sapkota BR, Schmidt R, Schmidt CO, Schminke U, Sharma P, Slowik A, Sudlow CLM, Tanislav C, Tatlisumak T, Taylor KD, Thijs VNS, Thorleifsson G, Thorsteinsdottir U, Tiedt S, Trompet S, Tzourio C, van Duijn CM, Walters M, Wareham NJ, Wassertheil-Smoller S, Wilson JG, Wiggins KL, Yang Q, Yusuf S, Consortium AF, Cohorts for H, Aging Research in Genomic Epidemiology C, International Genomics of Blood Pressure C, Consortium I, Starnet, Bis JC, Pastinen T, Ruusalepp A, Schadt EE, Koplev S, Bjorkegren JLM, Codoni V, Civelek M, Smith NL, Tregouet DA, Christophersen IE, Roselli C, Lubitz SA, Ellinor PT, Tai ES, Kooner JS, Kato N, He J, van der Harst P, Elliott P, Chambers JC, Takeuchi F, Johnson AD, BioBank Japan Cooperative Hospital G, Consortium C, Consortium E-C, Consortium EP-I, International Stroke Genetics C, Consortium M, Neurology Working Group of the CC, Network NSG, Study UKYLD, Consortium M, Sanghera DK, Melander O, Jern C, Strbian D, Fernandez-Cadenas I, Longstreth WT Jr, Rolfs A, Hata J, Woo D, Rosand J, Pare G, Hopewell JC, Saleheen D, Stefansson K, Worrall BB, Kittner SJ, Seshadri S, Fornage M, Markus HS, Howson JMM, Kamatani Y, Debette S, Dichgans M (2018) Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes. Nat Genet 50:524–537
Marshall NS, Wong KK, Cullen SR, Knuiman MW, Grunstein RR (2014) Sleep apnea and 20-year follow-up for all-cause mortality, stroke, and cancer incidence and mortality in the Busselton Health Study cohort. J Clin Sleep Med 10:355–362
Molnar MZ, Mucsi I, Novak M, Szabo Z, Freire AX, Huch KM, Arah OA, Ma JZ, Lu JL, Sim JJ, Streja E, Kalantar-Zadeh K, Kovesdy CP (2015) Association of incident obstructive sleep apnoea with outcomes in a large cohort of US veterans. Thorax 70:888–895
Munoz R, Duran-Cantolla J, Martinez-Vila E, Gallego J, Rubio R, Aizpuru F, De La Torre G (2006) Severe sleep apnea and risk of ischemic stroke in the elderly. Stroke 37:2317–2321
Osman AM, Carter SG, Carberry JC, Eckert DJ (2018) Obstructive sleep apnea: current perspectives. Nat Sci Sleep 10:21–34
Poggesi A, Pasi M, Pescini F, Pantoni L, Inzitari D (2016) Circulating biologic markers of endothelial dysfunction in cerebral small vessel disease: a review. J Cereb Blood Flow Metab 36:72–94
Ryan S (2018) Mechanisms of cardiovascular disease in obstructive sleep apnoea. J Thorac Dis 10:S4201–S4211
Semelka M, Wilson J, Floyd R (2016) Diagnosis and treatment of obstructive sleep apnea in adults. Am Fam Physician 94:355–360
Smith GD, Ebrahim S (2003) “Mendelian randomization”: can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol 32:1–22
Spiller W, Davies NM, Palmer TM (2019) Software application profile: mrrobust—a tool for performing two-sample summary Mendelian randomization analyses. Int J Epidemiol 48:684–690
Stewart J, Manmathan G, Wilkinson P (2017) Primary prevention of cardiovascular disease: a review of contemporary guidance and literature. JRSM Cardiovasc Dis 6:2048004016687211
Textor J, Hardt J (2011) DAGitty: a graphical tool for analyzing causal diagrams. Epidemiology 22:745
Verbanck M, Chen CY, Neale B, Do R (2018) Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet 50:693–698
Wang Y, Xu H, Qian Y, Guan J, Yi H, Yin S (2017) Patients with obstructive sleep apnea display decreased flow-mediated dilatation: evidence from a meta-analysis. Med Sci Monit 23:1069–1082
Woo D, Falcone GJ, Devan WJ, Brown WM, Biffi A, Howard TD, Anderson CD, Brouwers HB, Valant V, Battey TW, Radmanesh F, Raffeld MR, Baedorf-Kassis S, Deka R, Woo JG, Martin LJ, Haverbusch M, Moomaw CJ, Sun G, Broderick JP, Flaherty ML, Martini SR, Kleindorfer DO, Kissela B, Comeau ME, Jagiella JM, Schmidt H, Freudenberger P, Pichler A, Enzinger C, Hansen BM, Norrving B, Jimenez-Conde J, Giralt-Steinhauer E, Elosua R, Cuadrado-Godia E, Soriano C, Roquer J, Kraft P, Ayres AM, Schwab K, McCauley JL, Pera J, Urbanik A, Rost NS, Goldstein JN, Viswanathan A, Stogerer EM, Tirschwell DL, Selim M, Brown DL, Silliman SL, Worrall BB, Meschia JF, Kidwell CS, Montaner J, Fernandez-Cadenas I, Delgado P, Malik R, Dichgans M, Greenberg SM, Rothwell PM, Lindgren A, Slowik A, Schmidt R, Langefeld CD, Rosand J, International Stroke Genetics C (2014) Meta-analysis of genome-wide association studies identifies 1q22 as a susceptibility locus for intracerebral hemorrhage. Am J Hum Genet 94:511–521
Xie C, Zhu R, Tian Y, Wang K (2017) Association of obstructive sleep apnoea with the risk of vascular outcomes and all-cause mortality: a meta-analysis. BMJ Open 7:e013983
Yavorska OO, Burgess S (2017) MendelianRandomization: an R package for performing Mendelian randomization analyses using summarized data. Int J Epidemiol 46:1734–1739
Yeboah J, Redline S, Johnson C, Tracy R, Ouyang P, Blumenthal RS, Burke GL, Herrington DM (2011) Association between sleep apnea, snoring, incident cardiovascular events and all-cause mortality in an adult population: MESA. Atherosclerosis 219:963–968
Zaremba S, Albus L, Schuss P, Vatter H, Klockgether T, Guresir E (2019) Increased risk for subarachnoid hemorrhage in patients with sleep apnea. J Neurol 266:1351–1357
Acknowledgements
We would like to thank the national research infrastructure SIMPLER for provisioning of facilities and experimental support. The computations were performed on resources provided by the Swedish National Infrastructure for Computing’s (www.snic.se) support for sensitive data SNIC-SENS through the Uppsala Multidisciplinary Center for Advanced Computational Science (UPPMAX). We thank the MEGASTROKE and International Stroke Genetics consortia for providing summary statistics data for stroke.
Funding
Open access funding provided by Uppsala University. Work of the authors is supported by grants from the Börjeson, Emil and Ragna Foundation (to O.E.T.), the Swedish Research Council for Health, Working Life and Welfare (Forte; grant number 2018-00123) (to S.C.L.), the Swedish Research Council (Vetenskapsrådet; grant number 2016-01042 and 2019-00977) (to S.C.L.), and the Swedish Heart–Lung Foundation (Hjärt-Lungfonden; grant number 20190247) (to S.C.L.). The study was also supported by additional grants from the Swedish Research Council (https://www.vr.se; grant no 2015-03257, 2017-00644 and 2017-06100 to KM). SIMPLER receives funding through the Swedish Research Council under the grant no 2017-00644 (to Uppsala University and KM). SNIC is financially supported by the Swedish Research Council. The funding sources had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Author information
Authors and Affiliations
Contributions
OET and SCL contributed to the conception and design of the study; OET and SY contributed to the acquisition and analysis of data and are the guarantors of this work. OET drafted the article and prepared figures. All authors contributed to the interpretation of the results and critical revision of the article for important intellectual content and approved the final version of the article.
Corresponding author
Ethics declarations
Conflicts of interest
All authors declare that they have no conflict of interest. The authors have no relevant financial or non-financial interests to disclose.
Ethics approval and consent to participate
The cohort study was conducted following the Helsinki declaration, and the participants provided written informed consent. The current data analysis was approved by the Swedish Ethical Review Authority. Studies included in the GWASs had been approved by a relevant institutional review board and participants had provided informed consent. The present MR analysis has been approved by the Swedish Ethical Review Authority.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Titova, O.E., Yuan, S., Baron, J.A. et al. Sleep-disordered breathing-related symptoms and risk of stroke: cohort study and Mendelian randomization analysis. J Neurol 269, 2460–2468 (2022). https://doi.org/10.1007/s00415-021-10824-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-021-10824-y